Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 6 I, 1995, Pages 1887-1892

  Meijer, Gerda C ^a   Postma, Dirkje S ^b   Mulder, Paul G H ^b   Van Aalderen, Wim M C ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHACHOLINE; PLACEBO; SALMETEROL;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS REACTIVITY; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0028786417     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.6.8520751     Document Type: Article

References (31)

1. Fitzpatrick, M. F., H. Engleman, K. F. Whyte, I. J. Deary, C. M. Shapiro, and N. J. Douglas. 1991. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax 46:569-573.
2. Ullman, A., and N. Svedmyr. 1988. Salmeterol: a new long acting inhaled β2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674-678.
3. Britton, M. G., J. S. Earnshaw, and J. B. D. Palmer. 1992. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur. Respir. J. 5:1062-1087.
4. Lundbäck, B., D. W. Rawlinson, and J. B. D. Palmer. 1993. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 48:148-153.
5. Palmer, J. B. D., A. M. Stuart, G. L. Shepherd, and K. Viskum 1992. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease: a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg). Respir. Med. 86:409-417.
6. Pearlman, D. S., P. Chervinsky, C. LaForce, J. M. Seltzer, D. L. Southern, J. P. Kemp, R. J. Dockhorn, J. Grossman, R. F. Liddle, S. W. Yancey, D. M. Cocchetto, W. J. Alexander, and A. Van As. 1992. A comparison of salmeterol with albuterol in the treatment of mildto-moderate asthma. N. Engl. J. Med. 327:1420-1425.
7. Lötvall, J., H. Lunde, A. Ullman, H. Törnqvist, and N. Svedmyr. 1994. Twelve months treatment with inhaled salmeterol in asthmatic patients: effects on β-2-receptor function and inflammatory cells. Allergy 47:477-483.
8. Verberne, A. A. P. H., W. C. J. Hop, F. B. M. Creyghton, R. W. G. Van Rooij, M. Van den Berg, J. C. De Jongste, and K. F. Kerrebijn. 1994. Airway responsiveness after a single dose and during 4 months of treatment with salmeterol in asthmatic children (abstract). Am. J. Respir. Crit. Care Med. 149:A349.
9. Verberne, A. A. P. H., W. C. J. Hop, A. B. Bos, and K. F. Kerrebijn. 1993. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J. Allergy Clin. Immunol. 91:127-134.
10. 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J. Allergy Clin. Immunol. 89:567-574.
11. Green, C. P., and J. F. Price. 1992. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch. Dis. Child. 67:1014-1017.
12. Twentyman, O.P., J. P. Finnerty, A. Harris, J. Palmer, and S. T. Holgate. 1990. Protection against allergen-induced asthma by salmeterol. Lancet 336:1338-1342.
13. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
14. Ramage, L., B. J. Lipworth, C. G. Ingram, I. A. Cree, and D. P. Dhillon. 1994. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med. 88:363-368.
15. 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax 48:1121-1124.
16. Vathenen, A. S., A. J. Knox, B. G. Higgins, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet i:554-558.
17. 2-agonists treatment. Am. Rev. Respir. Dis. 148:702-712.
18. Van Essen-Zandvliet, E. E. M., M. D. Hughes, H. J. Waalkens, E. J. Duiverman, S. J. Pocock, and K. F. Kerrebijn. 1992. Effects of 22 months treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am. Rev. Respir. Dis. 146:547-554.
19. Van Aalderen, W. M. C., D. S. Postma, G. H. Koëter, and K. Knol. 1989. Circadian change in bronchial responsiveness and airflow obstruction in asthmatic children. Thorax 44:803-807.
20. Zapletal, A., M. Samanek, and T. Paul. 1987. Lung function in children and adolescents: methods, reference values. In A. Zapletal, editor. Progress in Respiration Research, Vol. 22. Karger, Basel. 114-218.
21. Greening, A. P., P. W. Ind, M. Northfield, and G. Shaw. 1994. Added salmeterol versus higher dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroids. Lancet 344:219-224.
22. d'Alonzo, G. E., R. A. Nathan, S. Henochowicz, R. J. Morris, P. Ratner, and S. I. Rennard. 1994. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. J.A.M.A. 271:1412-1416.
23. Fitzpatrick, M. F., T. Mackay, H. Driver, and N. J. Douglas. 1990. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled β2 agonist. B.M.J. 301:1365-1368.
24. Mackowiak, J. I., B. J. Lawrence, J. G. Boyer, and D. W. Aaronson. 1993. Effects of salmeterol on sleep scores using a quality of life instrument in patients with mild/moderate asthma (abstract). Am. Rev. Respir. Dis. 147:A60.
25. Kraan, J., G. H. Koëter, T. W. Van der Mark, H. J. Sluiter, and K. De Vries. 1985. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 76:628-636.
26. Wempe, J. B., E. P. Tammeling, D. S. Postma, B. Auffarth, J. P. Teengs, and G. H. Koëter. 1992. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma. J. Allergy Clin. Immunol. 90:349-357.
27. Brambilla, C., C. Chastang, D. Georges, and L. Bertin. 1994. Salmeterol compared with slow-release terbutaline in nocturnal asthma. Allergy 49:421-426.
28. Ullman, A., J. Hedner, and N. Svedmyr. 1990. Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis. Am. Rev. Respir. Dis. 142:571-575.
29. Platts-Mills, T. A. E., E. B. Mitchell, P. Nock, E. R. Tovey, H. Moszoro, and S. R. Wilkins. 1982. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet ii:675-678.
30. Howarth, P. H. 1992. Optimising asthma therapy: bronchial biopsies. In T. J. H. Clark and L. M. Fabbri, editors. Satellite Symposium of the First Annual Congress of the European Respiratory Society. Excerpta Med. 14.
31. Beach, J. R., C. L. Young, R. Harkawat, P. V. Gardiner, A. J. Avery, G. A. Coward, E. H. Walters, and D. J. Hendrick. 1993. Effect on airway responsiveness of six weeks treatment with salmeterol. Pulmon. Pharmacol. 6:155-157.